UK and US Finalize Pharmaceutical Deal

The United Kingdom and the United States have finalized a deal that eliminates tariffs on pharmaceuticals and medical devices for at least three years. This agreement includes a commitment from the UK to increase its spending on new medicines and a revised cost-effectiveness threshold for drug approvals. The deal is seen as a positive step for the UK’s life sciences sector and strengthens the ‘special relationship’ between the two countries.

Summarized from the sources above. Read the originals for the full story.